Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $92.94 million. The enterprise value is $72.75 million.
| Market Cap | 92.94M |
| Enterprise Value | 72.75M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 17.18 million shares outstanding. The number of shares has increased by 112.96% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +112.96% |
| Shares Change (QoQ) | +51.00% |
| Owned by Insiders (%) | 29.16% |
| Owned by Institutions (%) | 22.66% |
| Float | 7.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.47 |
| Forward PS | 3.33 |
| PB Ratio | 5.78 |
| P/TBV Ratio | 5.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | 23.19 |
| EV / EBIT | 23.19 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.10 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | n/a |
| Interest Coverage | 0.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -20.88% |
| Return on Invested Capital (ROIC) | -40.88% |
| Return on Capital Employed (ROCE) | 13.90% |
| Weighted Average Cost of Capital (WACC) | 17.00% |
| Revenue Per Employee | $488,961 |
| Profits Per Employee | -$234,553 |
| Employee Count | 76 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 6.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.21% in the last 52 weeks. The beta is 1.48, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -21.21% |
| 50-Day Moving Average | 5.89 |
| 200-Day Moving Average | 6.08 |
| Relative Strength Index (RSI) | 42.36 |
| Average Volume (20 Days) | 29,922 |
Short Selling Information
The latest short interest is 315,760, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 315,760 |
| Short Previous Month | 324,679 |
| Short % of Shares Out | 1.84% |
| Short % of Float | 4.00% |
| Short Ratio (days to cover) | 7.86 |
Income Statement
In the last 12 months, VRCA had revenue of $37.16 million and -$17.83 million in losses. Loss per share was -$1.31.
| Revenue | 37.16M |
| Gross Profit | 22.84M |
| Operating Income | -13.52M |
| Pretax Income | -17.83M |
| Net Income | -17.83M |
| EBITDA | 3.14M |
| EBIT | 3.14M |
| Loss Per Share | -$1.31 |
Balance Sheet
The company has $20.60 million in cash and $1.44 million in debt, with a net cash position of $19.16 million or $1.12 per share.
| Cash & Cash Equivalents | 20.60M |
| Total Debt | 1.44M |
| Net Cash | 19.16M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 16.06M |
| Book Value Per Share | 0.93 |
| Working Capital | 17.91M |
Cash Flow
| Operating Cash Flow | -14.11M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 466,000 |
| Net Borrowing | -44.26M |
| Free Cash Flow | -14.11M |
| FCF Per Share | -$0.82 |
Margins
Gross margin is 61.45%, with operating and profit margins of -36.39% and -47.97%.
| Gross Margin | 61.45% |
| Operating Margin | -36.39% |
| Pretax Margin | -47.97% |
| Profit Margin | -47.97% |
| EBITDA Margin | 8.44% |
| EBIT Margin | 8.44% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -112.96% |
| Shareholder Yield | -112.96% |
| Earnings Yield | -19.40% |
| FCF Yield | -15.36% |
Analyst Forecast
The average price target for VRCA is $15.54, which is 187.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.54 |
| Price Target Difference | 187.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 24.18% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -9.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.87 |
| Piotroski F-Score | 4 |